VYOME HOLDINGS, INC. Operating Lease, Liability, Noncurrent
VYOME HOLDINGS, INC. (HIND) had Operating Lease, Liability, Noncurrent of $8.15 thousand as of 2025-09-30, per its 10-Q filed 2025-11-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-03-18
- 2025-09-30: Operating Lease, Liability, Noncurrent $8.15K.
- 2025-06-30: Operating Lease, Liability, Noncurrent $16.73K.
- 2025-03-31: Operating Lease, Liability, Noncurrent $14.00K.
- 2024-12-31: Operating Lease, Liability, Noncurrent $32.83K; Operating Lease, Liability, Noncurrent as first filed $41.00K.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2025-09-30 | $8.15K 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $16.73K 8-K · filed 2025-09-02 | |
| 2025-03-31 | $14.00K 10-Q · filed 2025-05-20 | |
| 2024-12-31 | $32.83K 10-K · filed 2026-03-18 | $41.00K 10-K · filed 2025-04-04 |
| 2024-09-30 | $77.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $103.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $127.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $151.00K 10-K · filed 2025-04-04 | |
| 2023-09-30 | $175.00K 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $198.00K 10-Q · filed 2023-08-07 | |
| 2022-03-31 | $86.00K 10-Q · filed 2022-05-23 | |
| 2021-03-31 | $344.00K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $163.00K 10-K · filed 2022-04-08 | $438.00K 10-K · filed 2021-03-12 |
| 2019-12-31 | $567.00K 10-K · filed 2021-03-12 | |
| 2019-09-30 | $687.00K 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $722.00K 10-Q · filed 2019-07-24 | |
| 2019-03-31 | $819.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |